Texas Markets Continue to Top the Walgreens Flu Index List for Flu Activity
Wednesday, 03 January 2018 04:06
Jan. 3, 2018 14:30 UTC

Texas Markets Continue to Top the Walgreens Flu Index List for Flu Activity

Walgreens Flu Index™ for Week Ending December 30, 2017

DEERFIELD, Ill.--(BUSINESS WIRE)-- The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180103005217/en/

Walgreens Flu Index for the week ending December 30, 2017. (Graphic: Business Wire)

Walgreens Flu Index for the week ending December 30, 2017. (Graphic: Business Wire)

The Flu Index provides valuable insight by showing which cities or metropolitan areas are experiencing the most incidences of influenza each week based on Index methodology. The data does not measure actual levels or severity of flu activity.

With the ability to generate hyper-local data across most U.S. markets, the Flu Index is an online, interactive resource allowing anyone to search and find information regarding the most current state of influenza in their community.

To view this week’s Walgreens Flu Index, maps and other online features, including the ability to search by market name or state, click here.

 

Top 10 DMAs* with Flu Activity

Week Ending 12/30/17
 
1.   Tyler-Longview (Lufkin & Nacogdoches), Texas
2. Harlingen-Weslaco-Brownsville-McAllen, Texas
3. Waco-Temple-Bryan, Texas
4. Houston, Texas
5. Beaumont-Port Arthur, Texas
6. Corpus Christi, Texas
7. El Paso, Texas (Las Cruces, N.M.)
8. San Antonio, Texas
9. Dallas-Ft. Worth, Texas
10. Little Rock-Pine Bluff, Ark.
 

Top 10 States with Flu Activity

Week Ending 12/30/17
 
1. Texas
2. Arkansas
3. Iowa
4. West Virginia
5. Nebraska
6. Idaho
7. Tennessee
8. Arizona
9. Missouri
10. North Carolina
 

Top 10 DMAs with Flu Activity Gains

Week Ending 12/30/17

 
1. El Paso, Texas (Las Cruces, N.M.)
2. Des Moines-Ames, Iowa
3. San Antonio, Texas
4. Montgomery-Selma, Ala.
5. San Diego, Calif.
6. Reno, Nev.
7. La Crosse-Eau Claire, Wis.
8. Phoenix (Prescott), Ariz.
9. Lafayette, La.
10. Wausau-Rhinelander, Wis.
 

Top 10 States with Flu Activity Gains

Week Ending 12/30/17
 
1. Iowa
2. Arizona
3. Connecticut
4. California
5. Nebraska
6. South Dakota
7. Wisconsin
8. Minnesota
9. Kansas
10. Alabama
 

Methodology

The Walgreens Flu Index™ is compiled using weekly retail prescription data for antiviral medications used to treat influenza across Walgreens and Duane Reade locations nationwide, including Walgreens locations in Puerto Rico. The data is analyzed at state and geographic market levels to measure absolute impact and incremental change of antiviral medications on a per store average basis, and does not include markets in which Walgreens has fewer than 10 retail locations.

*Designated Market Area

About Walgreens

Walgreens (walgreens.com), a provider of trusted care in communities since 1901, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led, health and

wellbeing enterprise. Approximately 8 million customers interact with Walgreens in stores and

Error. Page cannot be displayed. Please contact your service provider for more details. (1)

online each day, using the most convenient, multichannel access to consumer goods and
services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,100 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services.

Contacts

Walgreens
Allison Mack
(847) 315-2932
allison.mack@walgreens.com


Source: Walgreens

Smart Multimedia Gallery

Walgreens Flu Index for the week ending December 30, 2017. (Graphic: Business Wire)

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20180103005217/en




BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BioMedReports F.D.A. names and shames drug makers to encourage generic competition https://t.co/pLdi3Yd8PR https://t.co/pLdi3Yd8PR
BioMedReports Trump’s lawyer pitched himself as a fixer to #Novartis and got paid $1.2 million https://t.co/8JKXtruRLL https://t.co/8JKXtruRLL
BioMedReports Judge Rules Biogen Must Face Federal Portion of FCA Complaint... https://t.co/WJL7BWxvOV
BMR:1